Concord Drugs Ltd.
| BSE: 538965 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE858L01010 |
| BSE 00:00 | 24 Jun | 21.25 |
-3.10 (-12.73%) |
OPEN
26.40 |
HIGH
26.40 |
LOW
19.50 |
| NSE 05:30 | 01 Jan | Concord Drugs Ltd |
| OPEN | 26.40 |
| PREVIOUS CLOSE | 24.35 |
| VOLUME | 5280 |
| 52-Week high | 37.40 |
| 52-Week low | 19.50 |
| P/E | 11.68 |
| Mkt Cap.(Rs cr) | 19 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Concord Drugs Ltd. (CONCORDDRUGS) - Financial Ratios
| Ratios | 2021 | 2020 | 2019 |
| Debt-Equity Ratio | 0.45 | 0.42 | 0.55 |
| Current Ratio | 1.59 | 1.32 | 1.18 |
| Asset turnover ratio | 1.55 | 1.66 | 1.56 |
| Inventory turnover ratio | 3.63 | 2.93 | 2.58 |
| Debtors turnover ratio | 2.22 | 1.39 | 0.80 |
| Interest Coverage ratio | 1.37 | 1.30 | 1.28 |
| Operating Margin (%) | 6.46 | 6.74 | 7.78 |
| Net Profit Margin (%) | 0.78 | 0.64 | 0.85 |
| Return on Capital Employed (%) | 5.01 | 5.61 | 5.69 |
| Return on Net Worth (%) | 1.59 | 1.42 | 1.93 |
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
